World News
-
Gilead, Carna Biosciences announce R&D collaboration
World | News | 0 Comment | 25 Jun, 2019
US headquartered Gilead Sciences and Japan based Carna Biosciences has announced that the companies have entered into a research and development collaboration to develop and commercial...Read more
-
World | News | 0 Comment | 25 Jun, 2019
A new research report projects that the global revenue of automated ESR analyzer market will account for revenues roughly equating US$ 495 Mn by the end of 2028. The rising prevalence of in...Read more
-
Glenmark, Novartis to promote respiratory products in Brazil
World | News | 0 Comment | 24 Jun, 2019
Glenmark has announced that its Brazilian subsidiary, Glenmark Farmacêutica Ltda has entered into an exclusive partnership agreement with Novartis Biosciences S.A, a subsidiary of Nov...Read more
-
World | News | 0 Comment | 24 Jun, 2019
Pfizer has announced that the European Commission approved TALZENNA (talazoparib), an oral poly (ADP-ribose) polymerase (PARP) inhibitor, as monotherapy for the treatment of...Read more
-
Canon Medical Showcases New Ultrasound Product Line at ASE 2019
World | News | 0 Comment | 24 Jun, 2019
Canon Medical Systems USA, Inc. is showcasing its innovative new line of ultrasound systems, the Aplio a-series, at this year’s American Society of Echocardiography (ASE) annual meeti...Read more
-
World | News | 0 Comment | 24 Jun, 2019
Vertex Pharmaceuticals Incorporated has announced that the U.S. Food and Drug Administration (FDA) approved SYMDEKO (tezacaftor/ivacaftor and ivacaftor) for use in children with cystic fibr...Read more
-
Ricoh announces strategic business partnership with Elixirgen Scientific
World | News | 0 Comment | 21 Jun, 2019
Ricoh Company, Ltd., has announced it has entered into a strategic business partnership with Elixirgen Scientific to develop innovative biomedical products and services that support drug di...Read more
-
Regeneron, Sanofi announce positive results for IL-33 antibody for asthma
World | News | 0 Comment | 21 Jun, 2019
Regeneron Pharmaceuticals and Sanofi have announced that a Phase 2 proof-of-concept trial evaluating the investigational IL-33 antibody REGN3500 (SAR440340) met the primary endpoi...Read more
-
Axovant, Yposkesi collaborate for gene therapy development
World | News | 0 Comment | 21 Jun, 2019
Axovant Gene Therapies Ltd., a clinical-stage company developing innovative gene therapies, today announces it has signed a strategic partnership with Yposkesi, a leading Contract Developme...Read more
-
PDS Biotechnology Corp gets U.S. and European patents for Versamune
World | News | 0 Comment | 21 Jun, 2019
PDS Biotechnology Corporation, a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced that the United ...Read more
-
AstraZeneca, NCCN collaborate for ovarian cancer treatment
World | News | 0 Comment | 21 Jun, 2019
The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) is collaborating with AstraZeneca, a global, science-led biopharmaceutical company, to further quality ...Read more
-
Optum completes acquisition of DaVita Medical Group from DaVita
World | News | 0 Comment | 21 Jun, 2019
Optum, a leading health services company, completed its acquisition of DaVita Medical Group, one of the nation’s leading independent medical groups, from DaVita Inc. As part of the tr...Read more
-
WHO highlights scarcity of treatment for epilepsy in low-income countries
World | News | 0 Comment | 21 Jun, 2019
Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma....Read more
-
Edesa biotech receives approval to proceed with its clinical investigation
World | News | 0 Comment | 20 Jun, 2019
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration has notified the company that it may proceed with its clinical investi...Read more
-
Verastem Oncology announces leadership changes
World | News | 0 Comment | 20 Jun, 2019
Verastem, a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced ...Read more
-
Genocea announces pricing of $36,750,000 public offering of common stock
World | News | 0 Comment | 20 Jun, 2019
Genocea Biosciences, a biopharmaceutical company developing personalized cancer immunotherapies has announced the pricing of its previously announced underwritten public offering of 10...Read more
-
Researchers develop mind-controlled robotic arm
World | News | 0 Comment | 20 Jun, 2019
A team of researchers from Carnegie Mellon University, in collaboration with the University of Minnesota, has made a breakthrough in the field of noninvasive robotic device contro...Read more
-
CyTuVax presents positive results of HBAI20 vaccine trial
World | News | 0 Comment | 19 Jun, 2019
CyTuVax B.V.has released the results of the HBAI20 Phase 2 “BE-Responder” trial. This trial focused on so-called non-responders to hepatitis B vaccination, persons who have been...Read more
